Usage of wobenzym in complex therapy of lyme disease
| dc.contributor.author | Shepylieva, N. | |
| dc.contributor.author | Bagmut, I. | |
| dc.contributor.author | Titkova, A. | |
| dc.contributor.author | Marakushyn, Dmytro | |
| dc.contributor.author | Sulhdost, I. | |
| dc.date.accessioned | 2017-12-06T08:35:13Z | |
| dc.date.available | 2017-12-06T08:35:13Z | |
| dc.date.issued | 2017-12 | |
| dc.description | Resuming the mentioned above it is important to underline that the carried out research revealed that LD course depending on the stage in our in- vestigations did not practically differ from the one described in literature. The treat- ment results appeared reliably better in patients who received wobenzym in complex therapy: recovery was marked in 92,5% of cases, in comparison group its number was 87,9%. Relapsing and chronic course in most cases was met in patients whose etiotropic treatment excluded wobenzym. Complex therapy caused more prominent effect, in comparison with monotherapy, directed on the disease clinical manifesta- tions elimination which confirms synergy of antibiotics with SET preparations. Be- sides in combined therapy prescription a tendency to more prominent than under monotherapy dynamics of immunological indices meanings to their normalization was marked. The reached therapeutical effect allows recommending the usage of SET in LD treatment. | ru_RU |
| dc.description.abstract | Duration of main clinical attributes and frequency of recurrent and chronic forms occurrence during the use of wobenzym in complex therapy were ana- lyzed in 87 patients with fixed diagnosis of Lyme disease. It was established that their duration shortened in 2,2 times (р<0,05). Accounting the data received the usage of wobenzym which potentiates the effect of antibiotics in complex therapy of Lyme dis- ease was validated. | ru_RU |
| dc.identifier.citation | Usage of wobenzym in complex therapy of lyme disease / N. V. Shepylieva, I. Yu. Bagmut, A. V. Titkova, D. I. Marakushyn, I. A. Sulhdost // Family Practice. – 2017. – Issue 6 (2), (December), volume 34. – P. 1449–1458. | ru_RU |
| dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/18529 | |
| dc.language.iso | en | ru_RU |
| dc.subject | Lyme disease | ru_RU |
| dc.subject | Borrelia | ru_RU |
| dc.subject | etiotropic therapy | ru_RU |
| dc.subject | wobenzym | ru_RU |
| dc.title | Usage of wobenzym in complex therapy of lyme disease | ru_RU |
| dc.type | Article | ru_RU |